Loading clinical trials...
Loading clinical trials...
An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Conditions
Interventions
Olumacostat Glasaretil Gel, 5.0%
Locations
94
United States
Avant Research Associates, LLC
Guntersville, Alabama, United States
Advanced Research Associates
Glendale, Arizona, United States
Alliance Dermatology & MOHS Center
Phoenix, Arizona, United States
Dermatology Trial Associates
Bryant, Arkansas, United States
Northwest Arkansas Clinical Trials Center
Rogers, Arkansas, United States
Anaheim Clinical Trials
Anaheim, California, United States
Start Date
March 21, 2017
Primary Completion Date
April 27, 2018
Completion Date
April 27, 2018
Last Updated
July 20, 2021
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
Dermira, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions